Dr. Felix Kratz Ph.D. Net Worth

Dr. Felix Kratz Ph.D. biography

Dr. Felix Kratz Ph.D. is the Sr. VP, Drug Devel. at LadRx Corp.

How old is Dr D?

Dr D is 58, he's been the Sr. VP、 Drug Devel. of LadRx Corp since . There are 7 older and 1 younger executives at LadRx Corp. The oldest executive at LadRx Corp is Louis Ignarro, 79, who is the Independent Director.

What's Dr D's mailing address?

Felix's mailing address filed with the SEC is 11726 SAN VICENTE BLVD., SUITE 650, LOS ANGELES, CA, 90049.

Insiders trading at LadRx Corp

Over the last 22 years, insiders at LadRx Corp have traded over 0$ worth of LadRx Corp stock and bought 3,710,406 units worth 8,711,088$ . The most active insiders traders include Steven A Kriegsman、Scott Bradford Patterson、Max Link. On average, LadRx Corp executives and independent directors trade stock every 177 days with the average trade being worth of 22,531$. The most recent stock trade was executed by Earl W Brien on 14 August 2020, trading 150,000 units of CYTR stock currently worth 39,000$.

What does LadRx Corp do?

LadRx Corp executives and stock owners

LadRx Corp executives and other stock owners filed with the SEC include:

• Steven Kriegsman,
  Chairman of the Board, Chief Executive Officer
• Steven A. Kriegsman,
  Chief Exec. Officer
• John Caloz,
  Chief Financial Officer, Chief Accounting Officer, IR Contact Officer
• John Y. Caloz,
  CFO, Treasurer & Sr. VP
• Louis Ignarro,
  Independent Director
• Joel Caldwell,
  Director
• Earl Brien,
  Director
• Dr. Felix Kratz Ph.D.,
  Sr. VP, Drug Devel.
• Cristina Newman,
  Corp. Sec.
• Terri Stevens,
  Chief Bus. Officer
• Molly Painter,
  Pres of USA and Head of Launch & Commercial Operations
• Molly Carey Poarch,
  Global & U.S. Head of Corp. Communications
• Jennifer K. Simpson,
  Director
• Anita J Chawla,
  Director
• Daniel J Levitt,
  Chief Medical Officer
• Joseph Rubinfeld,
  Director
• Olivia C Ware,
  Chief Commercial Officer
• Douglas Scott Wieland,
  Sr. VP - Drug Development
• Felix Kratz,
  Vice President Drug Discovery
• Herbert H Jr Mcdade,
  
• Alexander L Cappello,
  Director
• Raymond C Jr Carnahan,
  
• Ben Levin,
  Gen.Cnsl/VP Legal Affairs/Secy
• Eric Jay Selter,
  Director
• Cheryl Cohen,
  Director
• Scott Bradford Patterson,
  10% owner
• Marvin R Selter,
  Director
• Richard J Wennekamp,
  Director
• Max Link,
  Director
• David Scott Geyer,
  Sr. V.P. of Manufacturing
• Mitchell K Fogelman,
  Chief Financial Officer
• Jack R Barber,
  Sr VP - Drug Development
• Shi Chung Ng,
  Sr. VP Research & Development
• Matt Natalizio,
  Chief Financial Officer
• Mark Tepper,
  Vice President
• Stephen Snowdy,
  Chief Executive Officer